Published in J Am Acad Dermatol on November 01, 2002
Real-time fluorescence image-guided oncologic surgery. Adv Cancer Res (2014) 1.08
Pharmacological inhibitors of c-KIT block mutant c-KIT mediated migration of melanocytes and melanoma cells in vitro and in vivo. Oncotarget (2016) 0.81
Staged Excision for Lentigo Maligna and Lentigo Maligna Melanoma: Analysis of Surgical Margins and Long-term Recurrence in 68 Cases from a Single Practice. J Clin Aesthet Dermatol (2016) 0.78
Binocular Goggle Augmented Imaging and Navigation System provides real-time fluorescence image guidance for tumor resection and sentinel lymph node mapping. Sci Rep (2015) 0.78
An assessment of histological margins and recurrence of melanoma in situ. Plast Reconstr Surg Glob Open (2015) 0.75
A Left-Sided Prevalence of Lentigo Maligna: A UK Based Observational Study and Review of the Evidence. Dermatol Res Pract (2015) 0.75
Melanoma in Situ Treated with Topical Imiquimod for Management of Persistently Positive Margins: A Review of Treatment Methods. Ochsner J (2015) 0.75
Diagnosis and management of lentigo maligna: a review. Drugs Context (2015) 0.75
Recurrence Rate of Melanoma in Situ when Treated with Serial Disk Staged Excision: A Case Series. J Clin Investig Dermatol (2017) 0.75
Lentigo maligna melanoma with a history of cosmetic treatment: Prevalence, surgical outcomes and considerations. Lasers Surg Med (2017) 0.75
Case series of multiple recurrent reactive keratoacanthomas developing at surgical margins. Dermatol Surg (2009) 1.60
Comparative analysis of total body and dermatoscopic photographic monitoring of nevi in similar patient populations at risk for cutaneous melanoma. Dermatol Surg (2010) 1.46
Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center. Dermatol Surg (2015) 1.43
Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol (2003) 1.20
Dermatofibrosarcoma protuberans. J Natl Compr Canc Netw (2012) 1.11
Treatment of lentigo maligna with imiquimod before staged excision. Dermatol Surg (2007) 1.09
Metastatic melanoma - a review of current and future treatment options. Acta Derm Venereol (2015) 1.05
Digital dermoscopic monitoring of atypical nevi in patients at risk for melanoma. Dermatol Surg (2007) 0.90
Surgical margins for melanoma in situ. J Am Acad Dermatol (2012) 0.90
Sampling of melanocytic nevi for research purposes: a prospective, pilot study to determine effect on diagnosis. J Am Acad Dermatol (2008) 0.90
A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions. Arch Dermatol (2012) 0.89
Usefulness (or lack thereof) of immunophenotyping in atypical cutaneous T-cell infiltrates. Am J Clin Pathol (2006) 0.85
Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment. Dermatol Surg (2006) 0.85
Mohs micrographic surgery. Am Fam Physician (2005) 0.83
Histopathologic recognition of involved margins of lentigo maligna excised by staged excision: an interobserver comparison study. Arch Dermatol (2003) 0.82
CD158k/KIR3DL2 is a useful marker for identifying neoplastic T-cells in Sézary syndrome by flow cytometry. Cytometry B Clin Cytom (2008) 0.80
Immunohistochemical staining with Melan-A of uninvolved sun-damaged skin shows features characteristic of lentigo maligna. Dermatol Surg (2011) 0.79
Merkel cell carcinoma, version 1.2014. J Natl Compr Canc Netw (2014) 0.79
Use of a conchal bowl flap for repair of the earlobe. Arch Dermatol (2005) 0.79
Sentinel lymph node biopsy for melanoma in pregnant women. Ann Surg Oncol (2012) 0.78
Anatomic variability in superficial blood vessel and lymphatic vessel density. J Cutan Pathol (2010) 0.78
Lentigo maligna: one size does not fit all. Arch Dermatol (2011) 0.76
Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 0.76
Motivating factors for attendance of skin cancer screenings. J Am Acad Dermatol (2004) 0.75
Commentary: transecting melanomas: does it matter? Dermatol Surg (2013) 0.75
Use of physician assistants in Mohs micrographic surgery: a survey of fellowship-trained Mohs micrographic surgeons. Dermatol Surg (2010) 0.75
Risk factors for development of melanoma brain metastasis and disease progression: a single-center retrospective analysis. Melanoma Res (2017) 0.75